drugset
drugset / Trial / NCT07521241

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

NCT07521241 ↗

Phase 1 Not yet recruiting 52 enrolled Addpharma Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

Timeline

Start
2026-05
Primary completion
2026-06
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AD-230 Unknown — Oral
Subject AD-2301 Unknown — Oral

Indications

liver disorder